The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities:

• FDA Recommends Changes to Labeling for Transmucosal Buprenorphine Products Indicated to Treat Opioid Use Disorder

• One Lot of PROGRAF 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL 0.5mg (Tacrolimus Extended-Release Capsules) by Astellas Pharma: Recall - Due to Bottles Shipped to U.S. May Contain Empty Capsules

• Early Alert: Endoscope Accessories Forceps/Irrigation Plug Issue f…

Sign Up for Free Trial

---

• Back
• MCN Blog